Does chemotherapy reduce stress?

Palliative and Supportive Care

Volumn 8, Issue 4, 2010, Pages 455-460

  Gil, Francisco ^a   Costa, G ^b   Perez F J ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL DE MATARÓ   (Spain)

Author keywords

Cancer; Chemotherpy; Stress

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUSTMENT DISORDER; AGE; AMBULATORY CARE; ANXIETY DISORDER; ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL STRESS; MIDDLE AGED; NEOPLASM; PATHOLOGY; PREVALENCE; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SEX DIFFERENCE; SPAIN;

ADJUSTMENT DISORDERS; AGE FACTORS; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEOPLASMS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; RISK FACTORS; SEX FACTORS; SPAIN; STRESS, PSYCHOLOGICAL;

EID: 79952198013     PISSN: 14789515     EISSN: 14789523     Source Type: Journal    
DOI: 10.1017/S1478951510000337     Document Type: Article

References (18)

1. Akechi, T., Nakano, T., Akizuki, N., et al. (2002). Clinical factors associated with suicidality in cancer patients. Japanese Journal of Clinical Oncology, 32, 506-511. (Pubitemid 43102755)
2. Bell, K. (2009). "If it almost kills you that means it́s working." Cultural models of chemotherapy expressed in a cancer support group. Social Science and Medicine, 68, 169-176.
3. Charles, C., Redko, C., Whelan, T., et al. (1998). Doing nothing is no choice: Lay constructions of treatment decision-making among women with early-stage breast cancer. Sociology of Health and Illness, 20, 71-95.
4. Derogatis, L. R., Morrow, G. R., Fetting, J. et al. (1983). The prevalence of psychiatric disorders among cancer patients. Journal of the American Medical Association, 249, 751-757. (Pubitemid 13186788)
5. Gil, F., Costa, G., Pérez, F. J., et al. (2008). Adaptación psicológica y prevalencia de trastornos mentales en pacientes con cáncer (Psychological adaptation and prevalence of mental disorders in cancer patients). Medicina Clínica, 130, 90-92. (Pubitemid 351362733)
6. Grassi, L., Travado, L., Gil, F., et al. (2004). Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: Findings from the Southern European Psycho-Oncology Study. Journal of Affective Disorders, 83, 243-248. (Pubitemid 39536202)
7. Hack, T. F., Degner, L. F. & Dyck, D. G. (1994). Relationship between preferences for decisional control and illness information among women with breast cancer: A quantitative and qualitative analysis. Social Science Medicine, 39, 279-289. (Pubitemid 24166969)
8. Ibbotson, T., Maguire, P., Selby, P., et al. (1994). Screening for anxiety and depression in cancer patients: The effects of disease and treatment. European Journal of Cancer, 30, 37-40. (Pubitemid 24058086)
9. Jansen, S. J. T., Otten, W. & Stiggelbout, A. M. (2006). Factors affecting patientś perceptions of choice regarding adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment, 99, 35-45. (Pubitemid 44168601)
10. Kadan-Lottick, N. S., Van der Werker, L. C., Block, S. D., et al. (2005). Psychiatric disorders and mental health service use in patients with advanced cancer. Cancer, 104, 2872-2881.
11. Karnofsky, D. A. & Burchenal, J. H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, MacLeod, CM. (ed.). pp 191-205. New York: Columbia University Press.
12. Kim, J. W., Kim, S.-J., Kwon, J.-H., et al. (2008). Cancer patients awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives. British Journal of Cancer, 99, 1593-1599.
13. Martinez de la Iglesia, J., Dueñas, R., Onis, M. C., et al. (2001). Adaptación y validación al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 años (Adaptation and validation to Spanish of the Pfeiffer questionnaire (SPMSQ) for detecting cognitive deficit in adults older than 65 years). Medicina Clínica 1, 17, 129-134. (Pubitemid 33714072)
14. Razavi, D. & Delvaux, N. (1995). The psychiatrist's perspective on quality of life and quality of care in oncology: Concepts, symptom management, and communication issues. European Journal of Cancer, 31 A (Supp. 6), S25-S29.
15. Sahm, S., Will, R. & Hommel, G. (2005). What are cancer patients preferences about treatment at the end of life and who should start talking about it?. A comparison with healthy people and medical staff. Support Care Cancer, 13, 206-214. (Pubitemid 40576506)
16. SCID I y II. (1999). Guía de Entrevista Clínica Estructuradapara los Trastornos del eje I y II del DSM-IV[Structured Clinical Interview for the Psychiatric Disorders Axis I and II of the DSM-IV]. Editorial Masson.
17. Slevin, M. L., Stubbs, L., Plant, H. J., et al. (1990). Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. British Medical Journal, 300, 1458-1460. (Pubitemid 20195333)
18. Tejero, A., Guimerá, E. M., Farré, J. M., et al. (1986). Uso clínico del HAD (Hospital Anxiety and Depression Scale) en población psiquiátrica: un estudio de susensibilidad, fiabilidad y validez (Clinical use of HAD (Hospital Anxiety and Depresión Scale) in psychiatric population: an study of sensitivity, reliability and validation). Revista del Departamento de Psiquiatría de la Facultad de Medicine de Barcelona, 13, 233-238.